Literature DB >> 24999377

Biological substrates of addiction.

Max E Joffe1, Carrie A Grueter2, Brad A Grueter2.   

Abstract

This review is an introduction to addiction, the reward circuitry, and laboratory addiction models. Addiction is a chronic disease hallmarked by a state of compulsive drug seeking that persists despite negative consequences. Most of the advances in addiction research have centered on the canonical and contemporary drugs of abuse; however, addictions to other activities and stimuli also exist. Substances of abuse have the potential to induce long-lasting changes in the brain at the behavioral, circuit, and synaptic levels. Addiction-related behavioral changes involve initiation, escalation, and obsession to drug seeking and much of the current research is focused on mapping these manifestations to specific neural pathways. Drug abuse is well known to recruit components of the mesolimbic dopamine system, including the nucleus accumbens and ventral tegmental area. In addition, altered function of a wide variety of brain regions is tightly associated with specific manifestations of drug abuse. These regions peripheral to the mesolimbic pathway likely play a role in specific observed comorbidities and endophenotypes that can facilitate, or be caused by, substance abuse. Alterations in synaptic structure, function, and connectivity, as well as epigenetic and genetic mechanisms are thought to underlie the pathologies of addiction. In preclinical models, these persistent changes are studied at the levels of molecular pharmacology and biochemistry, ex vivo and in vivo electrophysiology, radiography, and behavior. Coordinating research efforts across these disciplines and examining cell type- and circuit-specific phenomena are crucial components for translating preclinical findings to viable medical interventions that effectively treat addiction and related disorders. WIREs Cogn Sci 2014, 5:151-171. doi: 10.1002/wcs.1273 Conflict of interest: The authors have declared no conflicts of interest for this article. For further resources related to this article, please visit the WIREs website.
© 2014 John Wiley & Sons, Ltd.

Entities:  

Year:  2014        PMID: 24999377      PMCID: PMC4078878          DOI: 10.1002/wcs.1273

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Cogn Sci        ISSN: 1939-5078


  168 in total

1.  The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking.

Authors:  Jennifer M Bossert; Robert F Busch; Sarah M Gray
Journal:  Neuroreport       Date:  2005-06-21       Impact factor: 1.837

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

3.  Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.

Authors:  J A Bibb; J Chen; J R Taylor; P Svenningsson; A Nishi; G L Snyder; Z Yan; Z K Sagawa; C C Ouimet; A C Nairn; E J Nestler; P Greengard
Journal:  Nature       Date:  2001-03-15       Impact factor: 49.962

4.  Kalirin-7 mediates cocaine-induced AMPA receptor and spine plasticity, enabling incentive sensitization.

Authors:  Xiaoting Wang; Michael E Cahill; Craig T Werner; Daniel J Christoffel; Sam A Golden; Zhong Xie; Jessica A Loweth; Michela Marinelli; Scott J Russo; Peter Penzes; Marina E Wolf
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

5.  Nucleus accumbens long-term depression and the expression of behavioral sensitization.

Authors:  Karen Brebner; Tak Pan Wong; Lidong Liu; Yitao Liu; Paul Campsall; Sarah Gray; Lindsay Phelps; Anthony G Phillips; Yu Tian Wang
Journal:  Science       Date:  2005-11-25       Impact factor: 47.728

6.  MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants.

Authors:  Jie V Deng; Ramona M Rodriguiz; Ashley N Hutchinson; Il-Hwan Kim; William C Wetsel; Anne E West
Journal:  Nat Neurosci       Date:  2010-08-15       Impact factor: 24.884

7.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

Review 8.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

Review 9.  Reward and aversion in a heterogeneous midbrain dopamine system.

Authors:  Stephan Lammel; Byung Kook Lim; Robert C Malenka
Journal:  Neuropharmacology       Date:  2013-04-08       Impact factor: 5.250

Review 10.  The mechanistic classification of addictive drugs.

Authors:  Christian Lüscher; Mark A Ungless
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

View more
  13 in total

1.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

2.  Genetic loss of GluN2B in D1-expressing cell types enhances long-term cocaine reward and potentiation of thalamo-accumbens synapses.

Authors:  Max E Joffe; Brandon D Turner; Eric Delpire; Brad A Grueter
Journal:  Neuropsychopharmacology       Date:  2018-06-25       Impact factor: 7.853

3.  GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation.

Authors:  Max E Joffe; Sophie R Vitter; Brad A Grueter
Journal:  Neuropharmacology       Date:  2016-03-21       Impact factor: 5.250

Review 4.  Neurotransmitter signaling through heterotrimeric G proteins: insights from studies in C. elegans.

Authors:  Michael R Koelle
Journal:  WormBook       Date:  2018-12-11

5.  mGlu1 and mGlu5 modulate distinct excitatory inputs to the nucleus accumbens shell.

Authors:  Brandon D Turner; Jerri M Rook; Craig W Lindsley; P Jeffrey Conn; Brad A Grueter
Journal:  Neuropsychopharmacology       Date:  2018-03-27       Impact factor: 7.853

Review 6.  Synaptic Plasticity in the Nucleus Accumbens: Lessons Learned from Experience.

Authors:  Brandon D Turner; Daniel T Kashima; Kevin M Manz; Carrie A Grueter; Brad A Grueter
Journal:  ACS Chem Neurosci       Date:  2018-01-24       Impact factor: 4.418

7.  Kappa opioid receptor modulation of excitatory drive onto nucleus accumbens fast-spiking interneurons.

Authors:  Benjamin C Coleman; Kevin M Manz; Brad A Grueter
Journal:  Neuropsychopharmacology       Date:  2021-08-16       Impact factor: 7.853

8.  Cocaine Experience Enhances Thalamo-Accumbens N-Methyl-D-Aspartate Receptor Function.

Authors:  Max E Joffe; Brad A Grueter
Journal:  Biol Psychiatry       Date:  2016-04-07       Impact factor: 13.382

Review 9.  Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders.

Authors:  Sean P Moran; James Maksymetz; P Jeffrey Conn
Journal:  Trends Pharmacol Sci       Date:  2019-11-08       Impact factor: 14.819

10.  Toll-like receptor 4 deficiency alters nucleus accumbens synaptic physiology and drug reward behavior.

Authors:  Daniel T Kashima; Brad A Grueter
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.